Case Report: IgA Nephropathy in a Patient With Anti-Transcription Intermediary Factor-1γ Antibody-Positive Dermatomyositis

被引:3
|
作者
Zhang, Suo [1 ,2 ]
Chen, Yu-Lan [1 ]
Liu, Cui-Lian [1 ]
Xie, Jing-Yi [1 ]
Sun, Bao-Dong [1 ]
Liu, Dong-Zhou [1 ]
机构
[1] Southern Univ Sci & Technol, Affiliated Hosp 1, Dept Rheumatol & Immunol, Jinan Univ,Clin Med Coll 2,Shenzhen Peoples Hosp, Shenzhen, Peoples R China
[2] Shenzhen Second Peoples Hosp, Dept Rheumatol & Immunol, Shenzhen, Peoples R China
来源
FRONTIERS IN IMMUNOLOGY | 2022年 / 13卷
基金
中国国家自然科学基金;
关键词
IgA nephropathy; systemic autoimmune myopathies; dermatomyositis; anti- transcription intermediary factor-1 gamma antibody; dermatomyositis-specific antibodies; RENAL INVOLVEMENT; POLYMYOSITIS; AUTOANTIBODIES; SPECTRUM; GLOMERULONEPHRITIS; CLASSIFICATION; DISEASE; RISK; LOCI;
D O I
10.3389/fimmu.2022.757802
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Immunoglobulin A nephropathy (IgAN) is the most common primary glomerulonephritis characterized by IgA deposits in the mesangial area of glomeruli. Connective tissue disorders are some of the most frequent causes of secondary IgAN. Nevertheless, IgAN rarely occurs in systemic autoimmune myopathies (SAMs). The present case study reports on a 58-year-old patient with dermatomyositis with positive anti-transcription intermediary factor (TIF)-1 gamma antibodies who was diagnosed with IgAN during standard immunosuppressive therapy. Moreover, we have made a systematic review regarding the association of SAMs and IgAN. To the best of the authors' knowledge, this is the first case study describing a patient with anti-TIF1 gamma antibody-positive dermatomyositis who developed IgAN, which demonstrates a potential relationship between anti-TIF1 gamma-positive dermatomyositis and IgAN. It is important for clinicians to be aware of the possibility of renal involvement in patients with SAMs, even in those with anti-TIF1 gamma-positive dermatomyositis.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Anti-nuclear matrix protein 2 antibody-positive dermatomyositis with gastrointestinal ulcers: A case report
    Uchio, Naohiro
    Komaki, Shogo
    Sudo, Takashi
    Matsumoto, Yusuke
    Hao, Akihito
    Kojima, Kentaro
    Toda, Nobuo
    Kitamura, Asuka
    Maeda, Meiko Hashimoto
    Kubota, Akatsuki
    Matsumoto, Hideyuki
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2023, 26 (12) : 2572 - 2575
  • [32] Clinical features of anti-TIF1-α antibody-positive dermatomyositis patients are closely associated with coexistent dermatomyositis-specific autoantibodies and anti-TIF1-γ or anti-Mi-2 autoantibodies
    Muro, Yoshinao
    Ishikawa, Asuka
    Sugiura, Kazumitsu
    Akiyama, Masashi
    RHEUMATOLOGY, 2012, 51 (08) : 1508 - 1513
  • [33] Amyopathic anti-TIF1-γ antibody-positive dermatomyositis in a young man
    Kluger, Nicolas
    JEADV CLINICAL PRACTICE, 2024, 3 (03): : 891 - 894
  • [34] Coexisting TIF1γ-positive Primary Pulmonary Lymphoepithelioma-like Carcinoma and Anti-TIF1γ Antibody-positive Dermatomyositis
    Nakanishi, Yu
    Yamaguchi, Kakuhiro
    Yoshida, Yusuke
    Sakamoto, Shinjiro
    Horimasu, Yasushi
    Masuda, Takeshi
    Nakashima, Taku
    Miyamoto, Shintarou
    Iwamoto, Hiroshi
    Hirata, Shintaro
    Fujitaka, Kazunori
    Hamada, Hironobu
    Sugiyama, Eiji
    Hattori, Noboru
    INTERNAL MEDICINE, 2020, 59 (20) : 2553 - 2558
  • [35] Case Report: Rapidly Progressive Interstitial Lung Disease in A Pregnant Patient With Anti-Melanoma Differentiation-Associated Gene 5 Antibody-Positive Dermatomyositis
    Chen, Cuihong
    Chen, Yulan
    Huang, Qin
    Hu, Qiu
    Hong, Xiaoping
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [36] Anti-TIF1γ antibody-positive dermatomyositis associated with nivolumab administration in a patient with advanced oesophageal squamous cell carcinoma: A case report and literature review
    Sakurai, Takuya
    Takahashi, Junichiro
    Komatsu, Teppei
    Mitsumura, Hidetaka
    Iguchi, Yasuyuki
    MODERN RHEUMATOLOGY CASE REPORTS, 2023, 7 (02) : 416 - 421
  • [37] Anti-TIF1γ antibody-positive dermatomyositis associated with durvalumab administration in a patient with lung and oesophageal cancers
    Imai, Ryosuke
    Ikemura, Sumie
    Jinta, Torahiko
    RESPIROLOGY CASE REPORTS, 2021, 9 (04):
  • [38] Autoantibody to transcriptional intermediary factor-1β as a myositis-specific antibody: clinical correlation with clinically amyopathic dermatomyositis or dermatomyositis with mild myopathy
    Ueda-Hayakawa, I.
    Hamaguchi, Y.
    Okiyama, N.
    Motegi, S.
    Yamaoka, T.
    Miyake, S.
    Higashi, A.
    Okamoto, H.
    Takehara, K.
    Fujimoto, M.
    BRITISH JOURNAL OF DERMATOLOGY, 2019, 180 (04) : 881 - 887
  • [39] A case of anti-NPX-2 antibody-positive dermatomyositis resulting in massive haemothorax with acquired factor XIII deficiency
    Matsuda, Takuya
    Haga, Taiki
    Sakaguchi, Takaaki
    Kan, Toshiaki
    Otsuka, Yasunori
    MODERN RHEUMATOLOGY CASE REPORTS, 2023, 8 (01) : 91 - 94
  • [40] Recurrence of anti-MDA5 antibody-positive clinically amyopathic dermatomyositis after long-term remission A case report
    Endo, Yushiro
    Koga, Tomohiro
    Ishida, Midori
    Fujita, Yuya
    Tsuji, Sosuke
    Takatani, Ayuko
    Shimizu, Toshimasa
    Sumiyoshi, Remi
    Igawa, Takashi
    Umeda, Masataka
    Fukui, Shoichi
    Nishino, Ayako
    Kawashiri, Shin-ya
    Iwamoto, Naoki
    Ichinose, Kunihiro
    Tamai, Mami
    Nakamura, Hideki
    Origuchi, Tomoki
    Kuwana, Masataka
    Hosono, Yuji
    Mimori, Tsuneyo
    Kawakami, Atsushi
    MEDICINE, 2018, 97 (26)